Literature DB >> 30118352

Absence of leptin signaling allows fat accretion in cystic fibrosis mice.

Ilya R Bederman1, Gavriella Pora1, Maureen O'Reilly1, James Poleman1, Kimberly Spoonhower1, Michelle Puchowicz2, Aura Perez1, Bernadette O Erokwu3, Alex Rodriguez-Palacios4, Chris A Flask1,3,5, Mitchell L Drumm1.   

Abstract

Negative energy balance is a prevalent feature of cystic fibrosis (CF). Pancreatic insufficiency, elevated energy expenditure, lung disease, and malnutrition, all characteristic of CF, contribute to the negative energy balance causing low body-growth phenotype. As low body weight and body mass index strongly correlate with poor lung health and survival of patients with CF, improving energy balance is an important clinical goal (e.g., high-fat diet). CF mouse models also exhibit negative energy balance (growth retardation and high energy expenditure), independent from exocrine pancreatic insufficiency, lung disease, and malnutrition. To improve energy balance through increased caloric intake and reduced energy expenditure, we disrupted leptin signaling by crossing the db/db leptin receptor allele with mice carrying the R117H Cftr mutation. Compared with db/db mice, absence of leptin signaling in CF mice (CF db/db) resulted in delayed and moderate hyperphagia with lower de novo lipogenesis and lipid deposition, producing only moderately obese CF mice. Greater body length was found in db/db mice but not in CF db/db, suggesting CF-dependent effect on bone growth. The db/db genotype resulted in lower energy expenditure regardless of Cftr genotype leading to obesity. Despite the db/db genotype, the CF genotype exhibited high respiratory quotient indicating elevated carbohydrate oxidation, thus limiting carbohydrates for lipogenesis. In summary, db/db-linked hyperphagia, elevated lipogenesis, and morbid obesity were partially suppressed by reduced CFTR activity. CF mice still accrued large amounts of adipose tissue in contrast to mice fed a high-fat diet, thus highlighting the importance of dietary carbohydrates and not simply fat for energy balance in CF. NEW & NOTEWORTHY We show that cystic fibrosis (CF) mice are able to accrue fat under conditions of carbohydrate overfeeding, increased lipogenesis, and decreased energy expenditure, although length was unaffected. High-fat diet feeding failed to improve growth in CF mice. Morbid db/db-like obesity was reduced in CF double-mutant mice by reduced CFTR activity.

Entities:  

Keywords:  cystic fibrosis; db/db mouse model; energy expenditure; hyperphagia; obesity

Mesh:

Substances:

Year:  2018        PMID: 30118352      PMCID: PMC6293256          DOI: 10.1152/ajpgi.00344.2017

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  48 in total

1.  Longitudinal investigation of energy expenditure in infants with cystic fibrosis.

Authors:  P S W Davies; J M Erskine; K M Hambidge; F J Accurso
Journal:  Eur J Clin Nutr       Date:  2002-10       Impact factor: 4.016

Review 2.  Genetic and physiological aspects of growth, body composition and feed efficiency in mice: a review.

Authors:  R C Malik
Journal:  J Anim Sci       Date:  1984-03       Impact factor: 3.159

3.  Energy expenditure and substrate utilization in adults with cystic fibrosis and diabetes mellitus.

Authors:  S A Ward; J L Tomezsko; D S Holsclaw; A M Paolone
Journal:  Am J Clin Nutr       Date:  1999-05       Impact factor: 7.045

4.  Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice.

Authors:  R S Surwit; M N Feinglos; J Rodin; A Sutherland; A E Petro; E C Opara; C M Kuhn; M Rebuffé-Scrive
Journal:  Metabolism       Date:  1995-05       Impact factor: 8.694

5.  Calculation of substrate oxidation rates in vivo from gaseous exchange.

Authors:  K N Frayn
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-08

6.  Plasma ghrelin and leptin in adult cystic fibrosis patients.

Authors:  Rubin I Cohen; Donna Tsang; Seth Koenig; David Wilson; Tom McCloskey; Subani Chandra
Journal:  J Cyst Fibros       Date:  2008-03-18       Impact factor: 5.482

7.  Energy expenditure, nutrition status, and body composition in children with cystic fibrosis.

Authors:  Verónica B Marín; Sylvia Velandia; Bessie Hunter; Vivien Gattas; Oscar Fielbaum; Oscar Herrera; Erik Díaz
Journal:  Nutrition       Date:  2004-02       Impact factor: 4.008

8.  Increased energy expenditure in young children with cystic fibrosis.

Authors:  R W Shepherd; T L Holt; L Vasques-Velasquez; W A Coward; A Prentice; A Lucas
Journal:  Lancet       Date:  1988-06-11       Impact factor: 79.321

Review 9.  Energy expenditure and genotype of children with cystic fibrosis.

Authors:  J L Tomezsko; V A Stallings; D A Kawchak; J E Goin; G Diamond; T F Scanlin
Journal:  Pediatr Res       Date:  1994-04       Impact factor: 3.756

10.  Fat, carbohydrate, and calories in the development of diabetes and obesity in the C57BL/6J mouse.

Authors:  Ann E Petro; Juliann Cotter; Dale A Cooper; John C Peters; Sarah J Surwit; Richard S Surwit
Journal:  Metabolism       Date:  2004-04       Impact factor: 8.694

View more
  4 in total

1.  Effects of ivacaftor on systemic inflammation and the plasma proteome in people with CF and G551D.

Authors:  Jordana E Hoppe; Brandie D Wagner; J Kirk Harris; Steven M Rowe; Sonya L Heltshe; Emily M DeBoer; Scott D Sagel
Journal:  J Cyst Fibros       Date:  2022-04-16       Impact factor: 5.527

2.  Small adipose stores in cystic fibrosis mice are characterized by reduced cell volume, not cell number.

Authors:  Ilya Bederman; Alex DiScenna; Leigh Henderson; Aura Perez; Jeannie Klavanian; Daniel Kovtun; Olivia Collins; John Dunn; Bernadette Erokwu; Christopher A Flask; Mitchell L Drumm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-09-06       Impact factor: 4.052

3.  Serum leptin and neuropeptide Y in patients with cystic fibrosis-A single center study.

Authors:  Sabina Galiniak; Rafał Podgórski; Marta Rachel; Artur Mazur
Journal:  Front Med (Lausanne)       Date:  2022-09-14

4.  Alleviation of depression-like behavior in a cystic fibrosis mouse model by Hdac6 depletion.

Authors:  Deborah A Corey; Sharon M Rymut; Thomas J Kelley
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.